当前位置: 首页 > 详情页

An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [2]Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200438, Peoples R China; [3]Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200438, Peoples R China; [4]Fudan Univ, Key Lab Reprod Regulat NPFPC SIPPR, Inst Reprod & Dev, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [5]Capital Med Univ, Beijing Insitute Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing 100029, Peoples R China; [6]Southeast Univ, Coinnovat Ctr Neuro Regenerat, Key Lab Dev Genes & Human Dis, Minist Educ,Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China; [7]Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [8]Soochow Univ, Inst Cardiovasc Sci, Affiliated Hosp 1, Suzhou 215007, Peoples R China; [9]Soochow Univ, Dept Cardiovasc Surg, Affiliated Hosp 1, Suzhou 215007, Peoples R China; [10]Fudan Univ, Childrens Hosp, 399 Wanyuan Rd, Shanghai 201102, Peoples R China
出处:
ISSN:

摘要:
Human pluripotent stem cells (hPSCs) represent a unique opportunity for understanding the molecular mechanisms underlying complex traits and diseases. CRISPR/Cas9 is a powerful tool to introduce genetic mutations into the hPSCs for loss-of-function studies. Here, we developed an episomal vector-based CRISPR/Cas9 system, which we called epiCRISPR, for highly efficient gene knockout in hPSCs. The epiCRISPR system enables generation of up to 100% Insertion/Deletion (indel) rates. In addition, the epiCRISPR system enables efficient double-gene knockout and genomic deletion. To minimize off-target cleavage, we combined the episomal vector technology with double-nicking strategy and recent developed high fidelity Cas9. Thus the epiCRISPR system offers a highly efficient platform for genetic analysis in hPSCs.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 2 区 综合性期刊
小类 | 2 区 综合性期刊
最新[2023]版:
大类 | 2 区 综合性期刊
小类 | 2 区 综合性期刊
JCR分区:
出版当年[2015]版:
Q1 MULTIDISCIPLINARY SCIENCES
最新[2023]版:
Q1 MULTIDISCIPLINARY SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China;
通讯作者:
通讯机构: [2]Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200438, Peoples R China; [3]Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200438, Peoples R China; [4]Fudan Univ, Key Lab Reprod Regulat NPFPC SIPPR, Inst Reprod & Dev, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [10]Fudan Univ, Childrens Hosp, 399 Wanyuan Rd, Shanghai 201102, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院